Archive | GHF2006

Public Responsibility in Research and Development Partnerships

A fatal imbalance exists in the investment in new drugs for neglected diseases, such as sleeping sickness and leishmaniasis, versus diseases prevalent in wealthy countries. From 1975 to 2004, of the 1,556 new drugs marketed only 21 just over one percent were for infectious tropical diseases and tuberculosis, in spite of the huge need.

Continue Reading
 

Partnerships to Promote Global Public Health Security

The emergence of new infectious diseases such as Severe Acute Respiratory Syndrome (SARS) and avian influenza A (H5N1); and the re-emergence of others such as cholera and yellow fever combined with the increased speed and volume of international travel and trade have alerted countries to the ease with which infectious diseases can cross national borders […]

Continue Reading
 
Skip to toolbar